Skip to main content
OpenTrials
Completed

NCT Number: NCT05109962

Management of Robertsonian Translocation PGT-SR Attempts

to analyze if a probe strategy choice for PGT-SR studies of Robertsonian translocations (RT) influences the fate of embryos? Few studies discussed the importance of probe choices. However, those who did, demonstrated that analysis with locus specific probes improve a diagnosis of dubious results, and addition of a centromeric probe could affect the accuracy of diagnosis

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Robertsonian Translocation

Age range

18 year and older

Sex eligibility

Female

Study type

Observational

Primary location

Uhmontpellier

Montpellier, 34295, France

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Adult patient whom carrying robertsonian translocations in the context of PGT-SR management
  • age > 18 years

Exclusion criteria

  • age < 18 years

Treatment and study plan

Primary outcomes

  1. Number of Participants with detect all chromosome segments

    Time frame: 1 day

    Number of Participants with detect all chromosome segments

Sponsors and collaborators

Lead sponsor

University Hospital, Montpellier

Other

Registry information

Official study title

New Recommendations for Robertsonian Translocation Management After Preimplantation Genetic Testing of Structural Rearrangement (PGT-SR) Attempts: What Should be Done With Mosaic Embryos?

Important dates

Study start
2006
Primary completion
2018
Study completion
2018
First posted
Nov 5, 2021
Registry last updated
Nov 16, 2021

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.